Patterns of Genomic Instability in Breast Cancer.
breast cancer
genomic instability
mutation signatures
Journal
Trends in pharmacological sciences
ISSN: 1873-3735
Titre abrégé: Trends Pharmacol Sci
Pays: England
ID NLM: 7906158
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
30
09
2018
revised:
14
12
2018
accepted:
08
01
2019
pubmed:
10
2
2019
medline:
7
3
2019
entrez:
10
2
2019
Statut:
ppublish
Résumé
Breast cancer is one of the most common cancers affecting women. Despite significant improvements in overall survival, it remains a significant cause of death worldwide. Genomic instability (GI) is a hallmark of cancer and plays a pivotal role in breast cancer development and progression. In the past decade, high-throughput technologies have provided a wealth of information that has facilitated the identification of a diverse repertoire of mutated genes and mutational processes operative across cancers. Here, we review recent findings on genomic alterations and mutational processes in breast cancer pathogenesis. Most importantly, we summarize the clinical challenges and opportunities to utilize omics-based signatures for better management of breast cancer patients and treatment decision-making.
Identifiants
pubmed: 30736983
pii: S0165-6147(19)30016-1
doi: 10.1016/j.tips.2019.01.005
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
198-211Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.